MAPK3 and Ewing sarcoma: Here we show that treatment with rapamycin activated PP2A and concurrently suppressed IGF-1 stimulated phosphorylation of Erk1/2 in human Ewing sarcoma (Rh1) and rhabdomyosarcoma (Rh30) cells.